Pedersen's POV graphic featuring MD+DI Senior Editor Amanda Pedersen and her quote about 23andMe. Pedersen's POV is a weekly op-ed about medtech.

Today's Research Daily features new research reports on 16 major stocks, including Oracle Corporation (ORCL), Micron ...

Defensive industries, like healthcare, are more attractive to income investors. That's because companies in this sector are ...

In 2023, Hugo found a home in the UK's Guy’s and St. Thomas’ Hospital NHS Foundation Trust. In May of 2024, Medtronic announced it is launching clinical studies of its Hugo robotic-assisted ...

In MedSurg, Medtronic is scaling the production of Hugo RAS. The Surgical and Neuroscience portfolios continues to contribute positively. Further, the company’s Pacing business continued to ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G ...

Medtronic in Santa Ana says its layoffs would be temporary while it repairs the roof of its medical device-making facility, while Avante Health Solutions in San Clemente hopes to retain its staff ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Medtronic is also developing a robotic-assisted surgery device, the Hugo system, that could prove to be an important long-term tailwind. Intuitive Surgical dominates this market, but given the ...